Pharmacokinetics of levonorgestrel and etonogestrel in rat or minipig following intravenous, subcutaneous, or intradermal administration

References

• Ananthula S, Janagam DR, Jamalapuram S, Johnson JR, Mandrell TD, Lowe TL. 2015. Development and validation of sensitive LC/MS/MS method for quantitative bioanalysis of levonorgestrel in rat plasma and application to pharmacokinetics study. J Chromatogr B Analyt Technol Biomed Life Sci. 1003:47–53.
   PubMed Web of Science ®Google Scholar
• Ding W, Qi X, Fu Q, Piao H. 2007. Pharmacokinetics and pharmacodynamics of sterylglucoside-modified liposomes for levonorgestrel delivery via nasal route. Drug Deliv. 14(2):101–104.
   PubMed Web of Science ®Google Scholar
• Düsterberg B. 1984. Plasma levels of levonorgestrel, gestodene, norethisterone and cyproterone acetate on single-dose subcutaneous administration in oily solution in the rat, beagle and rhesus monkey. Steroids. 43(1):43–56.
   PubMed Web of Science ®Google Scholar
• Düsterberg B, Beier S. 1984. Plasma levels and progestational activity of levonorgestrel after repeated intravenous and subcutaneous administration in the beagle bitch. Contraception. 29(4):345–357.
   PubMed Web of Science ®Google Scholar
• Düsterberg B, Hümpel M, Speck U. 1981. Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys. Contraception. 24(6):673–683.
   PubMed Web of Science ®Google Scholar
• Fischer J, Ganellin CR. 2006. Analogue-based drug discovery. Weinheim (DE): Wiley. Chapter 22, Corticosteroids: from natural products to useful analogues; p. 419–552.
   Google Scholar
• Gabelnick HL, Hall PE. 1987. Long-acting methods for fertility regulation. J Control Release. 6(1):387–394.
   Google Scholar
• Geelen JA, van der Wardt JT, Voortman G, Maassen GC, Eenink MJ. 1993. Release kinetics of 3-keto-desogestrel from contraceptive implants (Implanon®) in dogs: comparison with in vitro data. Contraception. 47(2):215–226.
   PubMed Web of Science ®Google Scholar
• He M, Yang G, Zhang S, Zhao X, Gao Y. 2018. Dissolving microneedles loaded with etonogestrel microcrystal particles for intradermal sustained delivery. J Pharm Sci. 107(4):1037–1045.
   PubMed Web of Science ®Google Scholar
• He M, Yang G, Zhao X, Zhang S, Gao Y. 2020. Intradermal implantable PLGA microneedles for etonogestrel sustained release. J Pharm Sci. 109(6):1958–1966.
   PubMed Web of Science ®Google Scholar
• Hu SX. 2017. Age-related change of hepatic uridine diphosphate glucuronosyltransferase and sulfotransferase activities in male chickens and pigs. J Vet Pharmacol Therap. 40(3):270–278.
   PubMed Web of Science ®Google Scholar
• Jenkins N, Fotherby K. 1981. Binding of the gestagens norethisterone and levonorgestrel in blood of various species. J Steroid Biochem. 14(10):1055–1062.
   PubMedGoogle Scholar
• Kuhnz W, Al-Yacoub G, Fuhrmeister A. 1992. Pharmacokinetics of levonorgestrel in 12 women who received a single oral dose of 0.15 mg levonorgestrel and, after a wash-out phase, the same dose during one treatment cycle. Contraception. 46(5):443–454.
   PubMed Web of Science ®Google Scholar
• Kuhnz W, Beier S. 1994. Comparative progestational and androgenic activity of norgestimate and levonorgestrel in the rat. Contraception. 49(3):275–289.
   PubMed Web of Science ®Google Scholar
• Kuhnz W, Fritzemeier KH, Hegele-Hartung C, Krattenmacher R. 1995. Comparative progestational activity of norgestimate, levonorgestrel-oxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptor. Contraception. 51(2):131–139.
   PubMed Web of Science ®Google Scholar
• Ma G, Song C, Sun H, Yang J, Leng X. 2006. A biodegradable levonorgestrel-releasing implant made of PCL/F68 compound as tested in rats and dogs. Contraception. 74(2):141–147.
   PubMed Web of Science ®Google Scholar
• MacCallum DM, Odds FC. 2002. Influence of grapefruit juice on itraconazole plasma levels in mice and guinea pigs. J Antimicrob Chemother. 50(2):219–224.
   PubMed Web of Science ®Google Scholar
• Mansour D, Inki P, Gemzell-Danielsson K. 2010. Efficacy of contraceptive methods: a review of the literature. Eur J Contracept Reprod Health Care. 15(1):4–16.
   PubMed Web of Science ®Google Scholar
• Margolskee A, Darwich AS, Galetin A, Rostami-Hodjegan A, Aarons L. 2016. Deconvolution and IVIVC: exploring the role of rate-limiting conditions. Aaps J. 18(2):321–332.
   PubMed Web of Science ®Google Scholar
• Nair KM, Sivakumar B, Rao BS. 1981. The rabbit as an animal model to study pharmacokinetics of levonorgestrel in women. Contraception. 23(1):89–98.
   PubMed Web of Science ®Google Scholar
• Naqvi RH, Mitra SB, Lindberg MC. 1984a. Effect of dose on the pharmacokinetics of levonorgestrel in the rat during the rapid elimination phase following subcutaneous administration. Contraception. 30(6):599–605.
   PubMed Web of Science ®Google Scholar
• Naqvi RH, Mitra SB, Saksena I, Lindberg MC. 1984b. Pharmacokinetics of levonorgestrel in the rat. Contraception. 30(1):81–88.
   PubMed Web of Science ®Google Scholar
• Renoir J, Mercier-Bodard C, Baulieu E. 1980. Hormonal and immunological aspects of the phylogeny of sex steroid binding plasma protein. Proc Natl Acad Sci USA. 77(8):4578–4582.
   PubMed Web of Science ®Google Scholar
• Shahiwala A, Misra A. 2004. Nasal delivery of levonorgestrel for contraception: an experimental study in rats. Fertil Steril. 81(1):893–898.
   PubMedGoogle Scholar
• Sully EA, Biddlecom A, Darroch JE, Riley T, Ashford LS, Lince-Deroche N, Firestein L, Murro R. 2020. Adding it up: investing in sexual and reproductive health 2019. New York (NY): Guttmacher Institute.
   Google Scholar
• US Food and Drug Administration (FDA) 1996. Jadelle: highlights of prescribing information. [Turku (FI)]: Bayer OY. [updated 2016 Dec 20; accessed 2021 Jun 15]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020544s010lbl.pdf.
   Google Scholar
• US Food and Drug Administration (FDA) 2001. Nexplanon: highlights of prescribing information. [Oss (NL)]: NV Organon. [updated 2020 Sep; accessed 2021 Nov 15]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021529s019s020lbl.pdf.
   Google Scholar
• Xu S, Hu A, Xie L, Liu J, Wu Q, Liu J. 2019. Age-associated changes of cytochrome P450 and related phase-2 gene/proteins in livers of rats. PeerJ. 7(e7249):e7429– 20.
   PubMedGoogle Scholar
• Xu Y, Prohn M, Cai X, Crutchlow M, Shankar SS, Bateman K, Woolf EJ. 2014. Direct comparison of radioimmunoassay and LC-MS/MS for PK assessment of insulin glargine in clinical development. Bioanalysis. 6(24):3311–3323.
   PubMed Web of Science ®Google Scholar